Mutual of America Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Mutual of America Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-39,081	Closed	-$1.78M	–	1722
2018 Q2	$1.78M	Hold	39,081	–	–	0.03%	940
2018 Q1	$2.06M	Hold	39,081	–	–	0.03%	840
2017 Q4	$2.66M	Buy	39,081 +268	+0.7%	+$18.7K	0.04%	734
2017 Q3	$3.2M	Hold	38,813	–	–	0.05%	604
2017 Q2	$3.63M	Buy	+38,813	New	+$2.37M	0.06%	515
2015 Q4	–	Sell	-16,800	Closed	-$1.54M	–	1264
2015 Q3	$1.54M	Buy	+16,800	New	+$1.45M	0.04%	784

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Mutual of America Capital Management's CLVS Position: Q3 2018 in Review

Mutual of America Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2018, closing a stake of 39,081 shares — an estimated $1.78M sold.

Mutual of America Capital Management first reported a position in CLVS in Q3 2015 and held it in 6 quarters. The position peaked at $3.63M in Q2 2017. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2018.

Mutual of America Capital Management reported no remaining Clovis Oncology, Inc. position as of Q3 2018 after selling out during the quarter.
Mutual of America Capital Management sold 39,081 Clovis Oncology, Inc. shares in Q3 2018, an estimated $1.78M.
Mutual of America Capital Management first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 6 quarters.
Mutual of America Capital Management's Clovis Oncology, Inc. position peaked at $3.63M in Q2 2017.
192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2018.

Based on Mutual of America Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.